Amanda Pedersen

In what could be called a turning point for robotic surgery, FDA has cleared da Vinci 5, the latest surgical robotics system from market pioneer Intuitive Surgical.

“This is not a small business. This will be in the top three spins in medical device history,” said Bryan Hanson, a veteran medtech executive tapped to serve as CEO of the new company.

The U.S. Patent Trial and Appeal Board revised its earlier decision regarding Medtronic patent claims challenged by Axonics in the sacral neuromodulation space.

Activist investor Politan wants to win two more seats on the Masimo board. The news broke just two days after the company said it would separate its consumer business from the company's core health tech business.

Johnson & Johnson is rumored to be close to reaching a deal with Shockwave Medical. The cardiovascular device company ranks among the 25 Most Attractive Medtech M&A Targets.

This week in Pedersen's POV, our senior editor revisits the trend of “biggering” in the medical device industry through a new lens.

For more than 40 years, MD+DI has served the industry as the leading source of in-depth news and information. MD+DI' s articles offer authoritative perspectives and provide a valuable reference on the full range of device industry issues. In addition to articles by leading experts on specific technology issues, broader features offer overviews of key business, industry, and regulatory topics.

Reprieve Cardiovascular recently emerged from stealth mode after raising $42 million in series A financing.

“Creaky” is my new favorite word to describe the antiquated Medicare reimbursement system, thanks to a physician and medtech entrepreneur who recently made a guest appearance on

At a Glance The recall comes about a month after the company recalled the HeartMate Touch Communication System.